C Reiter1, M Pfeiffer, R N Hullman. Show Affiliations » 1. Institute of Drug Safety, Bayer AG, Wuppertal, Federal Republic of Germany.
Abstract
Mesh: See more » AdolescentAdultAgedAged, 80 and overBacterial Infections/drug therapyChildCiprofloxacin/adverse effectsClinical Trials as TopicFemaleHumansMaleMiddle AgedSafetySurveys and Questionnaires
Substances: See more » Ciprofloxacin
Year: 1989 PMID: 2686408 DOI: 10.1016/0002-9343(89)90034-x
Source DB: PubMed Journal: Am J Med ISSN: 0002-9343 Impact factor: 4.965